Moderna, Merck Cancer Breakthrough Sparks Hope with mRNA Advances

Noubar Afeyan highlights recent progress in cancer therapy through mRNA technology. Moderna and Merck have developed a new medicine using this method, which is showing encouraging results in clinical settings.

Afeyan emphasizes that such innovations are possible when investment focuses on resolving uncertainty with data rather than opinion.

He has previously described science as a continuous process aimed at resolving uncertainty, not establishing fixed truths.